node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
AvBD1 | AvBD7 | ENSGALP00000035925 | ENSGALP00000030905 | Gallinacin-1; Has bactericidal activity. Potent activity against E.coli ML- 35, L.monocytogenes EGD and C.albicans. | Gallinacin-7; Has bactericidal activity. | 0.977 |
AvBD1 | CAMP | ENSGALP00000035925 | ENSGALP00000030658 | Gallinacin-1; Has bactericidal activity. Potent activity against E.coli ML- 35, L.monocytogenes EGD and C.albicans. | Cathelicidin-2; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | 0.931 |
AvBD1 | CATH1 | ENSGALP00000035925 | ENSGALP00000042184 | Gallinacin-1; Has bactericidal activity. Potent activity against E.coli ML- 35, L.monocytogenes EGD and C.albicans. | Cathelicidin-1; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | 0.900 |
AvBD1 | CATH3 | ENSGALP00000035925 | ENSGALP00000056590 | Gallinacin-1; Has bactericidal activity. Potent activity against E.coli ML- 35, L.monocytogenes EGD and C.albicans. | Cathelicidin-3; May bind bacterial lipopolysaccharide (LPS). May have antimicrobial activity and play a role in the innate immune response (By similarity). | 0.845 |
AvBD1 | CATHB1 | ENSGALP00000035925 | ENSGALP00000042265 | Gallinacin-1; Has bactericidal activity. Potent activity against E.coli ML- 35, L.monocytogenes EGD and C.albicans. | Cathelicidin-B1; Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). May play a role in the innate immune response. | 0.847 |
AvBD1 | DEFB4A | ENSGALP00000035925 | ENSGALP00000030904 | Gallinacin-1; Has bactericidal activity. Potent activity against E.coli ML- 35, L.monocytogenes EGD and C.albicans. | Gallinacin-2; Potent antibacterial activity against the Gram-negative bacterium E.coli ML-35, and against the Gram-positive bacterium L.monocytogenes EGD. Lacks antifungal activity against C.albicans. | 0.994 |
AvBD7 | AvBD1 | ENSGALP00000030905 | ENSGALP00000035925 | Gallinacin-7; Has bactericidal activity. | Gallinacin-1; Has bactericidal activity. Potent activity against E.coli ML- 35, L.monocytogenes EGD and C.albicans. | 0.977 |
AvBD7 | CAMP | ENSGALP00000030905 | ENSGALP00000030658 | Gallinacin-7; Has bactericidal activity. | Cathelicidin-2; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | 0.790 |
AvBD7 | CATH1 | ENSGALP00000030905 | ENSGALP00000042184 | Gallinacin-7; Has bactericidal activity. | Cathelicidin-1; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | 0.746 |
AvBD7 | CATH3 | ENSGALP00000030905 | ENSGALP00000056590 | Gallinacin-7; Has bactericidal activity. | Cathelicidin-3; May bind bacterial lipopolysaccharide (LPS). May have antimicrobial activity and play a role in the innate immune response (By similarity). | 0.763 |
AvBD7 | CATHB1 | ENSGALP00000030905 | ENSGALP00000042265 | Gallinacin-7; Has bactericidal activity. | Cathelicidin-B1; Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). May play a role in the innate immune response. | 0.706 |
AvBD7 | DEFB4A | ENSGALP00000030905 | ENSGALP00000030904 | Gallinacin-7; Has bactericidal activity. | Gallinacin-2; Potent antibacterial activity against the Gram-negative bacterium E.coli ML-35, and against the Gram-positive bacterium L.monocytogenes EGD. Lacks antifungal activity against C.albicans. | 0.978 |
CAMP | AvBD1 | ENSGALP00000030658 | ENSGALP00000035925 | Cathelicidin-2; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | Gallinacin-1; Has bactericidal activity. Potent activity against E.coli ML- 35, L.monocytogenes EGD and C.albicans. | 0.931 |
CAMP | AvBD7 | ENSGALP00000030658 | ENSGALP00000030905 | Cathelicidin-2; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | Gallinacin-7; Has bactericidal activity. | 0.790 |
CAMP | CATH1 | ENSGALP00000030658 | ENSGALP00000042184 | Cathelicidin-2; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | Cathelicidin-1; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | 0.988 |
CAMP | CATH3 | ENSGALP00000030658 | ENSGALP00000056590 | Cathelicidin-2; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | Cathelicidin-3; May bind bacterial lipopolysaccharide (LPS). May have antimicrobial activity and play a role in the innate immune response (By similarity). | 0.982 |
CAMP | CATHB1 | ENSGALP00000030658 | ENSGALP00000042265 | Cathelicidin-2; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | Cathelicidin-B1; Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). May play a role in the innate immune response. | 0.588 |
CAMP | DEFB4A | ENSGALP00000030658 | ENSGALP00000030904 | Cathelicidin-2; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | Gallinacin-2; Potent antibacterial activity against the Gram-negative bacterium E.coli ML-35, and against the Gram-positive bacterium L.monocytogenes EGD. Lacks antifungal activity against C.albicans. | 0.928 |
CAMP | JUN | ENSGALP00000030658 | ENSGALP00000037247 | Cathelicidin-2; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | Transcription factor AP-1; Transcription factor that recognizes and binds to the enhancer heptamer motif 5'-TGA[CG]TCA-3'. May be involved in activated KRAS-mediated transcriptional activation of USP28. May bind to the USP28 promoter; Belongs to the bZIP family. Jun subfamily. | 0.902 |
CAMP | NFKB1 | ENSGALP00000030658 | ENSGALP00000036814 | Cathelicidin-2; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | Nuclear factor NF-kappa-B p105 subunit; P105 is the precursor of the p50 subunit of the nuclear factor NF-kappa-B, which binds to the kappa-B consensus sequence 5'- GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. The precursor protein itself does not bind to DNA. | 0.904 |